Shares of Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €37.03 ($40.25) and traded as high as €37.35 ($40.60). Fresenius Medical Care shares last traded at €35.36 ($38.43), with a volume of 732,943 shares changing hands.
Fresenius Medical Care Trading Up 1.2 %
The stock has a market capitalization of $10.66 billion, a price-to-earnings ratio of 19.84, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a current ratio of 1.46, a quick ratio of 0.80 and a debt-to-equity ratio of 77.56. The company has a fifty day moving average of €36.90 and a two-hundred day moving average of €37.04.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Battle of the Retailers: Who Comes Out on Top?
- Profitably Trade Stocks at 52-Week Highs
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Investing In Automotive Stocks
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.